• Sequans received an NYSE non-compliance notice on Sept. 14 over continued-listing market capitalization rules under Section 802.01B.
• NYSE flagged a 30-trading-day average global market cap below $50 million alongside stockholders’ equity below $50 million.
• The notice does not trigger immediate delisting of Sequans’ ADSs.
• The company has 90 days to submit a plan to regain compliance within a 9-month cure period.
• NYSE will decide within 45 days of receiving the plan whether continued listing can continue during the cure period.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sequans Communications SA published the original content used to generate this news brief via Newsfile (Ref. ID: 202609231645NEWSFILECNPR____20260923_315755_1) on September 23, 2026, and is solely responsible for the information contained therein.